Does Ketamine Therapy Get You High? What a Session Feels Like
Ketamine therapy can bring a brief, dreamlike altered state, but a monitored treatment session is a different thing from a recreational high. What people report, why dose and setting matter, and how fast it passes.

Ketamine therapy can produce a short-lived altered state, but it is not the same as getting high recreationally. In research, most participants felt strange, spacey, or detached during treatment, and about one in four reported euphoria. Those effects usually peaked within the first hour and faded within about two hours. In a clinic, a clinician sets the dose for you, watches you throughout, and you recover on site before anyone takes you home.
Does ketamine therapy get you high?
Not in the way most people mean the word. Ketamine can briefly change how you sense your body, time, and surroundings, and some people find part of that pleasant. But a treatment session is built around a measured dose, a medical setting, and a clinician paying attention to you, which makes it a very different experience from taking ketamine to get intoxicated.
The effect people notice most is dissociation: a temporary feeling of being cut off from your own thoughts and feelings, or from your sense of where and when you are. The FDA lists it, with sedation and changes in vital signs, among the effects a health care provider should watch for when compounded ketamine is used.
The doses tested for depression are described in research as subanesthetic, meaning lower than the amounts used to put someone under for surgery.
What does ketamine therapy feel like?
For most people it feels strange more than anything else. Researchers at the National Institute of Mental Health pooled side-effect reports from several of their trials, in which participants received a single dose of ketamine through a vein. Among people who had both ketamine and a placebo, these were some of the experiences reported after ketamine:
- Feeling strange, weird, or spacey: roughly three in four
- Feeling woozy or loopy: close to three in four
- Dissociation: about six in ten
- Changes in how things look, or a sense of floating: a little over half
- Numbness, or finding it harder to get words out: about half
- Dizziness or feeling faint: a little over one in three
- Euphoria: about one in four, against almost no one after placebo
Does the route of the dose change the experience?
It may. The figures above come from intravenous doses given in a research unit. Our clinic gives ketamine as a small injection under the skin instead. In a small trial that compared intravenous, intramuscular, and subcutaneous injections, the subcutaneous route caused the fewest side effects, and side effects rose as the dose went up.
In a larger trial of subcutaneous ketamine given twice a week, about three in four people in the flexible-dose group still reported dissociation in the hour after a dose, so expect to feel something. Experiences vary between people, and between one session and the next.
How is ketamine therapy different from recreational use?
The medicine is ketamine either way, but almost everything around it is different. The National Institute on Drug Abuse (NIDA) explains that the health risks of ketamine depend on how much someone takes, whether it is combined with other drugs, and how often and for how long it is used. NIDA also warns that unsupervised use carries serious risks, including breathing that becomes dangerously slow and shallow.
- Dose: in treatment, a clinician calculates the dose for the individual. NIDA notes that higher doses can bring extreme detachment from body and reality, which people call a k-hole.
- Combinations: according to NIDA, the most serious problems linked to ketamine have come from mixing it with other drugs, especially opioids or GHB.
- Frequency: NIDA links long-term, heavy use with memory problems, depression, anxiety, and a bladder condition known as ketamine-induced uropathy.
- Supervision: the FDA has cautioned that compounded ketamine used without a provider checking for sleepiness, dissociation, and vital-sign changes may expose patients to serious adverse events.
How long do the effects of a session last?
The strongest effects are usually brief. In the NIMH analysis, most side effects peaked within an hour of the dose and had resolved by two hours, and they rarely carried over into the next day. In the multicenter subcutaneous trial, the acute effects, including perceptual changes and rises in blood pressure, settled within the two-hour observation period.
Sleepiness is also a common short-term effect, which is one reason recovery is built into every visit here. Each visit, from preparation through monitored recovery, runs about 90 minutes to two hours. Afterward a responsible adult has to take you home, and you should stay off the road yourself until the following day.
Does it feel the same every time?
Not necessarily. In a placebo-controlled trial that gave intravenous ketamine two or three times a week, dissociative symptoms were temporary and became weaker with repeated doses.
None of this makes ketamine harmless. It is a Schedule III controlled substance, and the FDA lists abuse and misuse among its known safety concerns. That is why, at our clinic, it is only ever given on site with a clinician present, and never prescribed for use at home.
Request a consultation
A conversation, not a commitment. Please don't include medical records, diagnosis details, or anything urgent — this form is not monitored for emergencies.
In person or by telehealth
You can be seen both ways. Consultations, planning conversations, and follow-up visits happen in person at our Tampa clinic or by telehealth — whichever works better for you.
Ketamine itself is always administered in person, at the clinic, with a clinician monitoring you throughout. We do not prescribe ketamine for use at home.
Telehealth visits require you to be physically located in Florida at the time of the visit.
How telehealth works here
- Telehealth is available to patients who are physically located in Florida, and the clinicians providing that care hold active Florida licenses.
- Your location is confirmed at the start of every telehealth visit. If you are not in Florida, the visit does not go ahead.
- Ketamine is never prescribed for you to take at home. It is administered only at our clinic, in person, with a clinician monitoring you throughout — a telehealth visit does not change that.
- You are seen in person before any treatment session, because every session happens at the clinic.
- A telehealth visit never guarantees that treatment will be offered, any more than an in-person evaluation does.
- Telehealth is not for emergencies. If you are in crisis or having thoughts of self-harm, call or text 988, or call 911.
Common questions
No. In research, about one in four participants felt euphoric after a dose and most did not. The sensations people notice during a session are side effects that pass within hours. What matters in treatment is whether depressive symptoms improve over the following days and weeks, and that is what your plan is reviewed against.
Ketamine has misuse potential, and the FDA lists abuse and misuse among its known safety concerns. In the pooled NIMH analysis, researchers saw no rise in craving after a single supervised dose, though they noted they had not formally measured craving or dependence. Here, ketamine is given only at the clinic and is never sent home with anyone.
In a trial of subcutaneous ketamine, about three in ten people felt anxious in the hour after a dose, so feeling uneasy as the effects build is not unusual. A clinician monitors you for the entire session, so you are never handling it alone, and the acute effects pass. Say how you are feeling at any point; that information helps the clinician.
No. Even if you feel clear-headed, plan for a responsible adult to collect you and take you home after every visit. Ketamine can cause sleepiness and dizziness, so do not drive yourself anywhere until the next day. Build this into your plans before your first session.
Sources & further reading
- Comprehensive assessment of side effects associated with a single dose of ketamine in treatment-resistant depression (Acevedo-Diaz et al., 2020) — Journal of Affective Disorders, via PubMed Central. Accessed 2026-11-02. Pooled analysis of NIMH trials of a single intravenous dose. Side-effect proportions are from Table 3.
- Ketamine — National Institute on Drug Abuse. Accessed 2026-11-02.
- FDA warns patients and health care providers about potential risks associated with compounded ketamine products, including oral formulations, for the treatment of psychiatric disorders — U.S. Food and Drug Administration. Accessed 2026-11-02. October 10, 2023 alert, listed on FDA's Compounding Risk Alerts index.
- Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression (Loo et al., 2016) — Acta Psychiatrica Scandinavica, via PubMed. Accessed 2026-11-02.
- Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study) (Loo et al., 2023) — British Journal of Psychiatry, via PubMed Central. Accessed 2026-11-02.
- A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression (Singh et al., 2016) — American Journal of Psychiatry, via PubMed. Accessed 2026-11-02.
Links point to external organizations. Clear Ketamine Therapy does not control their content.
Reviewed by Editorial team. Last reviewed 2026-11-02. Educational information only — not medical advice or a substitute for care from your own clinicians.
Keep reading
- What to ExpectA plain-language walkthrough of the full treatment process at our Tampa clinic — the evaluation, the sessions themselves, and the follow-up — including the parts that vary from person to person.
- Safety & Side EffectsThe full safety picture: common short-term side effects, who should not receive ketamine, the FDA's compounded-ketamine warning, and our monitoring practices.
- Subcutaneous vs IV KetamineHow subcutaneous, intravenous, and intramuscular ketamine differ, what the trials of the subcutaneous route found, and what is still unknown. Our clinic uses the subcutaneous route only.
- In-Clinic vs At-Home KetamineAt-home ketamine programs and in-clinic treatment are two different models of care. What the FDA has said about compounded ketamine used without monitoring, and what that means for your choice.
Talk with our clinical team
A consultation is a conversation, not a commitment. Ask questions, share what you are comfortable sharing, and learn whether ketamine therapy may be worth considering for you.
Not for emergencies — call or text 988 or 911 if you are in crisis.
